Amedisys (AMED) PT Lowered to $180 at Raymond James
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 2 | New: 2
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 2 | New: 2
Join SI Premium – FREE
Raymond James analyst John Ransom lowered the price target on Amedisys (NASDAQ: AMED) to $180.00 (from $200.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Upgrades Domino's Pizza Enterprises Ltd. (DMP:AU) (DPZUF) to Buy
- Ultragenyx Pharma (RARE) PT Raised to $50 at Wells Fargo
- Resimac Group Ltd (RMC:AU) PT Raised to AUD0.85 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
